title: Therapies for allergic inflammation: refining strategies to induce tolerance.
abstract: Current therapies for asthma and allergy are relatively safe and effective at controlling symptoms but do not change the chronic course of disease. There is no established method to prevent asthma and allergy, and major unmet needs in this area include the better control of the severe forms of these diseases and the developments of curative therapies. Two major therapeutic strategies for asthma and allergy are currently being developed, and I here discuss the advances and challenges for future therapeutic development in these two areas. The first approach, allergen-specific immunotherapy, aims to induce specific immune tolerance and has a long-term disease-modifying effect. The second approach is the use of biological immune response modifiers to decrease pathological immune responses. Combination strategies using both of these approaches may also provide a route for addressing the unmet clinical needs in allergic diseases.
authors.affiliation: Swiss Institute of Allergy and Asthma Research, University of Zurich, Switzerland. akdisac@siaf.uzh.ch
authors.forename: Cezmi A
authors.initials: CA
authors.lastname: Akdis
mesh_terms: D000818:Animals; D001249:Asthma / Q000276:immunology / Q000628:therapy*; D001491:Basophils / Q000502:physiology; D016207:Cytokines / Q000037:antagonists & inhibitors; D003888:Desensitization, Immunologic; D004804:Eosinophils / Q000502:physiology; D006801:Humans; D007108:Immune Tolerance; D007073:Immunoglobulin E / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D008407:Mast Cells / Q000502:physiology; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D016207:Cytokines; D007074:Immunoglobulin G; D007073:Immunoglobulin E